Cell Medica Switzerland AG;The University of North Carolina at Chapel Hill
发明人:
Dotti, Gianpietro,Landoni, Elisa,Shamshiev, Abdijapar,Kretzschmar, Titus,Droste, Miriam,Philips, Douglas
申请号：
AU2017223846
公开号：
AU2017223846A1
申请日:
2017.02.24
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The present invention relates to engineered immune cells expressing antigen receptors, such as a T cell receptor (TCR) or a chimeric antigen receptor (CAR), as well as antibody targeting PD-Ll. Also provided are related nucleic acids, vectors, compositions and method for enhancing the immune response towards cancers and pathogens.
